Information Hub
Access guidance, webcasts and publications with commentaries using the ABS Information Hub. Search by classification or using keywords.
To view the webcasts from previous ABS Conferences, events and webinars you must be an ABS member and be logged in using your membership username and password.
-
menu_book
This EBCTCG meta-analysis investigated whether pre-menopausal women treated with ovarian suppression benefited from aromatase inhibitors (AIs). Meta-analysis was performed from individual patient data...
n/a | National Library of Medicine
23.03.2022 | Added: 23.03.2022
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine Therapy
menu_bookPublication menu_book -
menu_book
Duration of adjuvant aromatase-inhibitor therapy in postmenopausal breast cancer
This prospective randomised trial assigned postmenopausal women with HR-positive breast cancer who had received 5 years of adjuvant endocrine therapy (n=3484) to receive either additional 2 or 5 years...
Michael Gnant et al | The New England Journal of Medicine
28.07.2021 | Added: 28.07.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine Therapy
menu_bookPublication menu_book -
menu_book
This prospective multicentre trial investigated the accuracy of ultrasound-guided biopsies identifying breast pathologically complete response (pCR) after neoadjuvant systemic therapy (NST) in patient...
Ariane A van Loevezijn et al | National Library of Medicine
28.06.2021 | Added: 28.06.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Systemic therapy Trials
menu_bookPublication menu_book -
menu_book
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
Andrew N.J Tutt et al | The New England Journal of Medicine
03.06.2021 | Added: 03.06.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Adjuvant treatment BRCA
menu_bookPublication menu_book -
desktop_windows
Sponsored Symposium: MDT case studies using the Prosigna test result in early breast cancer patients
ABS | ABS Conference 2021
21.05.2021 | Added: 21.05.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Gene Expression Profiling
desktop_windowsWebcast desktop_windows -
desktop_windows
Neoadjuvant Endocrine Treatment
ABS | ABS Conference 2021
17.05.2021 | Added: 17.05.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy
desktop_windowsWebcast desktop_windows -
desktop_windows
ABS | ABS Conference 2021
17.05.2021 | Added: 17.05.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Gene Expression Profiling
desktop_windowsWebcast desktop_windows -
menu_book
This study aimed to examine the planned long-term recurrence and survival outcomes from the ELIOT trial. Eligible women, aged 48-75 years with a clinical diagnosis of a unicentric breast carcinoma wit...
Prof Roberto Orecchia et al | The Lancet Oncology
01.05.2021 | Added: 01.05.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Trials Intraoperative Radiotherapy
menu_bookPublication menu_book -
menu_book
This study sought to identify factors predictive of distant metastatic disease at presentation to enable appropriate selection of patients for pretreatment CT. A total of 1377 patients with newly diag...
N Roszkowski et al | British Journal of Surgery
14.03.2021 | Added: 14.03.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
menu_bookPublication menu_book -
desktop_windows
5th MFAC meeting 17 February 2021
Mammary Fold | Webinar
17.02.2021 | Added: 17.02.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
menu_book
This systematic review and meta-analysis examined whether the timing of surgery post-neoadjuvant chemotherapy (NACT) impacted overall survival (OS) and disease free survival (DFS). Five studies (inclu...
Carolyn Cullinane et al | European Journal of Surgical Oncology
09.02.2021 | Added: 09.02.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT Breast Surgery
menu_bookPublication menu_book -
desktop_windows
ABS | 6th MDT meeting sessions.
25.01.2021 | Added: 25.01.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
desktop_windows
Surgical considerations post NACT
ABS | 6th MDT meeting sessions.
25.01.2021 | Added: 25.01.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
desktop_windows
Personalised Breast Cancer treatment
ABS | 6th MDT meeting sessions
25.01.2021 | Added: 25.01.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
list
Endocrine treatment for breast cancer
ABS have produced an up to date guideline on endocrine therapy for early breast cancer patients
Association of Breast Surgery, UK
01.01.2021 | Added: 01.01.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy
listGuideline list -
desktop_windows
Webinar 1: Indications for and management of patients having neoadjuvant chemotherapy
ABS | Webinar
23.06.2020 | Added: 23.06.2020
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Neoadjuvant Chemotherapy/ NACT
desktop_windowsWebcast desktop_windows -
menu_book
This study examined pathological complete response (pCR) in the breast and the axilla in 4084 patients treated with neoadjuvant chemotherapy (NACT). The data was derived from the Netherlands Cancer Re...
Sanaz Samiei MD et al | Annals of Surgical Surgery
01.03.2020 | Added: 01.03.2020
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Systemic therapy Axilla Pathological Response
menu_bookPublication menu_book -
Oncology update on adjuvant extended endocrine treatment and adjuvant bisphosphonates
Dr Catherine Harper-Wynne | ABS Conference 2019
13.05.2019 | Added: 13.05.2019
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine therapy Bisphosphonates
